Study guide
16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments
Philippine Medical Technologists Licensure Examination MTLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety
1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards
2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function
2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice
3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology
3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology
4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety
4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms
5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria
5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology
6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology
6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods
7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods
7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control
8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders
8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry
9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders
9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests
10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing
10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures
11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions
11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin
12 Chapter 12: Clinical Serology and Immunology
12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)
13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology
13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control
14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens
14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens
15 Chapter 15: Histopathologic Techniques and Cytotechnology
15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records
16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics
16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics
16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments
Key Takeaways Explain This Topic AI
Republic Act No. 5527 was approved on June 21, 1969, establishing statutory governance for medical technology in the Philippines, with crucial subsequent revisions enacted under RA 6138 (1970), PD 498 (1974), and PD 1534 (1978).
The Professional Regulatory Board of Medical Technology consists of a Pathologist as Chairman and two Registered Medical Technologists as Members, appointed by the President of the Philippines upon PRC recommendation for a 3-year term.
Passing the MTLE requires a general weighted average of at least 75%, no grade below 50% in any major 20% subject, and failing in less than 60% of the total examination subjects by relative weight.
An examinee who fails the MTLE three times is statutorily disqualified from taking further examinations until completing a 12-month refresher course in an accredited medical technology school or 12-month postgraduate training in an accredited laboratory (Section 19).
Administrative disciplinary actions by the Board mandate distinct voting thresholds: revocation of a Certificate of Registration requires a unanimous vote (3 out of 3 members), whereas license suspension requires a majority vote (2 out of 3 members) for a maximum duration of two years.
Last updated: October 2026
Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments
The practice of medical technology in the Philippines is governed by a well-defined statutory framework centered on Republic Act No. 5527 , widely recognized as "The Philippine Medical Technology Act of 1969." Medical technologists must master this organic act along with its amendatory decrees, board resolutions, and professional regulatory protocols. This section details the legislative provisions, examination ratings, board configurations, and disciplinary rules evaluated on the Philippine Medical Technologists Licensure Examination (MTLE).
- 1. Legislative Foundation and Historical Evolution ┌────────────────────────────────────────────────────────┐
- │ Republic Act No. 5527 (Approved: June 21, 1969) │
- │ "The Philippine Medical Technology Act" │
- └──────────────────────────┬─────────────────────────────┘
- │
- ┌─────────────────────────────────────┼─────────────────────────────────────┐
- ▼ ▼ ▼
- ┌──────────────┐ ┌──────────────┐ ┌──────────────┐
- │ RA No. 6138 │ │ PD No. 498 │ │ PD No. 1534 │
- │(Aug 31, 1970)│ │(June 28, 1974│ │(June 11, 1978│
- └──────┬───────┘ └──────┬───────┘ └──────┬───────┘
- │ │ │
- Amended Sec 16 • Amended Sections 2, 3, • Amended Sec 3
- (exam quals), 4, 7, 8, 11, 13, 16, (Council), Sec 8
- Sec 21 (COR 17, 21, and 29 (Board quals), and
- issuance), and • Board placed under PRC Sec 13 (training
- Sec 22 (fees) • MLT registration via labs via DOH-BRL)
- Sec 21 (rating ≥70%) • Repealed Sec 11 (g),(i)
Approval Date : Republic Act No. 5527 was approved and signed into law by President Ferdinand E. Marcos on June 21, 1969 .
Amendatory Acts and Presidential Decrees :
Republic Act No. 6138 (Approved August 31, 1970) : The first legislative amendment. It revised Section 16 (qualifications for examination), Section 21 (issuance of the certificate of registration, including registration without examination), and Section 22 (fees), and took effect retroactively as of June 21, 1969.
Presidential Decree No. 498 (Signed June 28, 1974) : Issued during the Martial Law period, PD 498 amended Sections 2, 3, 4, 7, 8, 11, 13, 16, 17, 21, and 29. It redefined the practice of medical technology, placed the Board under the Professional Regulation Commission, revised the Council, expanded the 10% subject to cover cytotechnology, medical technology laws, related laws, and the Code of Ethics, and allowed registration of Medical Laboratory Technicians without examination under Section 21. It did not change the Section 19 passing rules.
Presidential Decree No. 1534 (Signed June 11, 1978) : Amended Section 3 (composition of the Council of Medical Technology Education), paragraph 3 of Section 8 (degree qualification of Board members), and Section 13 (the Department of Education and Culture approves schools, and the DOH through the Bureau of Research and Laboratories approves training laboratories, both in conjunction with the Board). It also repealed subparagraphs (g) and (i) of Section 11. Its preamble explains that PD 498 had hampered DECS and DOH functions and prejudiced the practice of pathology by qualified physicians.
2. Core Statutory Definitions (Section 2)
Section 2 of RA 5527 (as amended by PD 498) establishes the statutory definitions that delineate professional boundaries:
Practice of Medical Technology (Section 2(a), as amended by PD 498): A person who, for a fee, salary, or other compensation or reward paid directly or indirectly, renders any of the following professional services to aid the physician in the diagnosis, study, and treatment of diseases and in the promotion of health in general:
Examination of tissues, secretions, and excretions of the human body and body fluids by electronic, chemical, microscopic, bacteriologic, hematologic, serologic, immunologic, nuclear, and other laboratory procedures, manual or automated;
- Blood banking procedures and techniques;
- Parasitologic, mycologic, and microbiologic procedures and techniques;
Histopathologic and cytotechnology (a registered medical laboratory technician may still perform histopathologic techniques);
Clinical research involving patients or human beings that requires medical technology knowledge and procedures;
Preparation and standardization of reagents, standards, stains, and similar materials used exclusively in the laboratory;
Clinical laboratory quality control;
Collection and preservation of specimens.
A person licensed in another regulated profession is not covered by the last four items when performing them is merely incidental to that profession.
Pathologist (Section 2(b)): A duly registered physician specially trained in methods of laboratory medicine, or in the gross and microscopic study and interpretation of tissues, secretions, and excretions of the human body, to diagnose disease, follow its course, determine the effectivity of treatment, ascertain cause of death, and advance medicine by research.
Medical Technologist (Section 2(c)): A person who engages in the work of medical technology under the supervision of a pathologist, or of a licensed physician authorized by the DOH where there is no pathologist, and who, having completed the prescribed course (BS Medical Technology or BS Hygiene) and passed the examination, is registered under the Act.
Medical Laboratory Technician (Section 2(d), as amended by PD 498): A person certified and registered with the Board as qualified to assist a medical technologist and/or qualified pathologist in the practice of medical technology. Under Section 21 (as amended by PD 498), the Board registers an MLT without examination if the applicant:
Passed the civil service examination for medical technician given on March 21, 1964 ; or
Finished a 2-year college course and has at least one (1) year of experience as a medical laboratory technician (two years of experience may substitute for each year of missing college study), or had at least ten (10) years of MLT experience when PD 498 took effect, regardless of academic attainment; or
Failed the medical technology board examination but obtained a general rating of at least 70% (that is, 70% to below 75%).
Accredited Medical Technology Training Laboratory (Section 2(e)): A clinical laboratory, office, agency, clinic, hospital, or sanitarium duly approved by the DOH or its authorized agency. Under Section 13 (as amended by PD 1534), the DOH through the Bureau of Research and Laboratories approves training laboratories for students and postgraduate trainees in conjunction with the Board.
3. Governance: Council of Medical Technology Education and the PRC Board
RA 5527 creates two distinct administrative bodies: an educational policy body (The Council) and a professional regulatory body (The Board).
The Council of Medical Technology Education (Sections 3 & 4)
Functions (Section 5) : Recommends the minimum required curriculum; determines how many students each school may admit; approves schools and recommends closure of substandard ones; requires annual school reports; inspects schools; certifies students who have completed three years of the course for internship; and formulates the refresher course for applicants who fail the board examination for the third time.
Composition (Section 3, as amended by PD 1534) :
- Chairman : Director of Higher Education (these higher-education functions now rest with CHED);
- Vice-Chairman : Chairman of the Professional Regulation Commission;
Members :
- Director of the Bureau of Research and Laboratories of the DOH;
- The Chairman and two (2) members of the Board of Medical Technology;
- A representative of the Deans of Schools of Medical Technology and Public Health;
The Presidents of the Philippine Society of Pathologists (PSP) and the Philippine Association of Medical Technologists (PAMET).
The Professional Regulatory Board of Medical Technology (Sections 7 & 8)
Structure and Composition : Operates under the administrative supervision of the Professional Regulation Commission (PRC):
Chairman : A duly licensed Pathologist ;
Two Members : Both Registered Medical Technologists (RMTs) .
Appointment and Term of Office (Section 7, as amended by PD 498) : Appointed by the President of the Philippines upon recommendation of the Professional Regulation Commission . Members hold office for three (3) years after appointment or until their successors are appointed and qualified; a successor named after a death, disability, or removal serves only the unexpired balance of the term.
Statutory Qualifications of Board Members (Section 8) :
- Must be a citizen of the Philippines;
- Must be of good moral character;
Must be a qualified Pathologist or a duly registered Medical Technologist with a degree in BS Medical Technology, BS Hygiene, or Public Health;
Must have been in the practice of laboratory medicine or medical technology for at least ten (10) years before appointment (this applies to the chairman and both members);
Must not have been a member of the faculty of any medical technology school for at least two (2) years prior to appointment , nor have any direct or indirect pecuniary interest in such an institution.
4. MTLE Architecture, Subject Weightings, and Passing Algorithms
The Philippine Medical Technologists Licensure Examination is administered semi-annually (traditionally in March and August/September) by the PRC.
Examination Subjects and Relative Weights (Section 17)
- Subject Relative Weight Classification
- Clinical Chemistry 20% Major Board Subject
- Microbiology and Parasitology 20% Major Board Subject
- Hematology 20% Major Board Subject
- Blood Banking and Serology 20% Major Board Subject
- Clinical Microscopy (Urinalysis/Body Fluids) 10% Minor Board Subject
- Histopathologic Techniques, Cytotechnology, Laws & Ethics 10% Minor Board Subject
- Total Aggregate 100%
- Statutory Passing Algorithm (Section 19)
To pass the licensure examination, an examinee must satisfy all three statutory criteria simultaneously :
Obtain a general weighted average of at least 75% on the written examination;
Must not have a rating below 50% in any major subject (the four subjects weighted at 20%: Clinical Chemistry, Microbiology/Parasitology, Hematology, Blood Banking/Serology);
Must not have failed in at least 60% of the subjects computed according to their relative weights (i.e., passing subjects must represent more than 40% of the aggregate board weighting).
The Three-Failure Refresher Rule (Section 19)
Under Section 19 of RA 5527 (a section that neither RA 6138 nor PD 498 amended): Candidate with 3 MTLE Failures ⟶ { 12-Month Refresher Course in Accredited School, OR 12-Month Postgraduate Training in an Accredited Laboratory ⟶ Re-examination Eligible \text{Candidate with 3 MTLE Failures} \longrightarrow \begin{cases} \text{12-Month Refresher Course in Accredited School, OR} \\ \text{12-Month Postgraduate Training in an Accredited Laboratory} \end{cases} \longrightarrow \text{Re-examination Eligible} Candidate with 3 MTLE Failures ⟶ { 12-Month Refresher Course in Accredited School, OR 12-Month Postgraduate Training in an Accredited Laboratory ⟶ Re-examination Eligible
No further examination shall be granted to an applicant who has failed the examination three (3) times , unless and until they complete either:
A twelve (12)-month refresher course in an accredited medical technology school; or
A twelve (12)-month postgraduate training in an accredited laboratory.
A graduate of another paramedical profession admitted to the examination under the Act is given no further examination after failing a third time.
- 5. Issuance, Renewal, Revocation, and Suspension of Certificate of Registration
- Registration and Identification Cards (Sections 20 to 22)
Successful examinees take a professional oath (Section 20) before the Board or any person authorized to administer oaths, and are issued a Certificate of Registration (COR) (Section 21). No COR is issued to a successful examinee younger than 21 years . The COR is signed by the Board members and the PRC Commissioner, and the medical technologist must display it where they work.
PRC sets the current fees: the examination fee for the 2026 MTLE was PHP 900 \text{PHP }900 PHP 900 , and registration fees for the COR and identification card are charged separately.
The Professional Identification Card (PIC) is renewed every three (3) years , contingent upon compliance with the mandatory Continuing Professional Development (CPD) credit requirements.
Grounds for Refusal of COR (Section 23) : The Board shall refuse to issue a certificate to any person convicted by a court of competent jurisdiction of any criminal offense involving moral turpitude , any person guilty of immoral or dishonorable conduct , any person of unsound mind , or any person with an incurable communicable disease , and must give the applicant a written statement of the reason.
Administrative Sanctions: Revocation vs. Suspension (Section 24)
Administrative investigations are conducted by at least two Board members with one legal officer , observing the rules of evidence and the respondent's constitutional rights (counsel, a speedy and public hearing, and cross-examination). The statute defines voting thresholds for the penalties: ┌──────────────────────────────────────────────┐
- │ Board Administrative Disciplinary │
- │ Voting Thresholds │
- └──────────────────────┬───────────────────────┘
- │
- ┌────────────────────────┴────────────────────────┐
- ▼ ▼
- ┌──────────────────────┐ ┌──────────────────────┐
- │ REVOCATION │ │ SUSPENSION │
- │ (Permanent Stripping)│ │(Max Term: Two Years) │
- └──────────┬───────────┘ └──────────┬───────────┘
- │ │
- UNANIMOUS VOTE MAJORITY VOTE
- (3 out of 3) (2 out of 3)
- All 3 must concur Any 2 of the 3 members
Revocation of Certificate of Registration :
Requires a UNANIMOUS VOTE (3 out of 3 members) of the Board.
Grounds: the causes in Section 23, the offenses listed in Section 29 (such as a fraudulent laboratory report), unprofessional conduct, malpractice, incompetency, serious ignorance, or gross negligence in practice.
Suspension of Certificate of Registration :
Requires a MAJORITY VOTE (2 out of 3 members) of the Board.
The statutory duration of suspension must never exceed two (2) years ; the Board may also reprimand by majority vote.
The medical technologist must surrender the certificate within 30 days after the decision becomes final, on pain of perpetual disqualification for inexcusable failure; a suspension runs from the date of surrender.
Penal Provisions (Section 29)
Offenses include practicing without registration (or exemption); practicing, even when registered, without the supervision of a qualified pathologist or DOH-authorized physician; knowingly making a fraudulent laboratory report; failing to display the certificate after a Board warning; using another person's certificate or a revoked or suspended one; giving false evidence to obtain registration; impersonating a registrant; using a title implying registration; and employing an unregistered person as a medical technologist or medical laboratory technician. Offenders shall, upon conviction, be punished by a fine of not less than PHP 2,000 \text{PHP }2{,}000 PHP 2 , 000 nor more than PHP 5,000 \text{PHP }5{,}000 PHP 5 , 000 , or by imprisonment for not less than six (6) months nor more than two (2) years , or both, at the discretion of the court.